BMC veterinary research · 2026
Effect of dietary chitosan supplementation on intestinal barrier function and growth performance in weaned piglets challenged by Enterohemorrhagic Escherichia coli.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Jiahao, De Blasio Simona, Xie Kunhong, Li Xiang, Luo Yuheng, Zheng Ping, Mao Xiangbing, Yan Hui, Wang Quyuan, Good Liam, Pelligand Ludovic, He Jun
Аннотация
BACKGROUND: Enterohemorrhagic Escherichia coli O157:H7 (EHEC) is an important zoonotic pathogen that disrupts intestinal epithelial barrier integrity and induces excessive inflammatory responses, leading to impaired growth performance and intestinal injury. EHEC is also an important cause hemolytic uremic syndrome (HUS) in children and older adults. In pig production, chitosan is considered a promising alternative to antibiotics due to its bioadhesive and antimicrobial properties, but the effects and underlying mechanisms of chitosan (COS) under pathogenic challenge remain to be elucidated.
RESULTS: One hundred and eight pigs were randomly divided into three treatment groups: an unchallenged control (CON), an EHEC-challenged control (ECON), and an EHEC-challenged group supplemented with 100 mg/kg COS (ECOS). Results show that EHEC challenge increased the feed conversion ratio (FCR), increased inflammatory cytokine levels, disrupted intestinal morphology, and downregulated tight junction and nutrient transporter gene expression (P < 0.05). Dietary COS supplementation decreased FCR during days 6-14 (P < 0.05) and tended to improve average daily gain (ADG) over the same period (0.05 < P < 0.10). Moreover, COS tended to decrease faecal shedding of total E. coli (P = 0.085) and EHEC, attenuated systemic inflammation by decreasing serum TNF-α and IL-6 levels, and enhanced humoral immunity as indicated by increased IgA and IgM concentrations (P < 0.05). Importantly, COS alleviated EHEC-induced intestinal injury by restoring villus height and villus-to-crypt ratio, with enhanced mucosal digestive enzyme activities, and upregulated expression of tight junction proteins (ZO-1 and occludin) and nutrient transporters (SGLT-1 and PEPT1) (P < 0.05).
CONCLUSIONS: In conclusion, these findings indicate that dietary COS improves growth performance in EHEC-challenged weaned pigs, with enhanced intestinal barrier integrity and nutrient transport capacity.
RESULTS: One hundred and eight pigs were randomly divided into three treatment groups: an unchallenged control (CON), an EHEC-challenged control (ECON), and an EHEC-challenged group supplemented with 100 mg/kg COS (ECOS). Results show that EHEC challenge increased the feed conversion ratio (FCR), increased inflammatory cytokine levels, disrupted intestinal morphology, and downregulated tight junction and nutrient transporter gene expression (P < 0.05). Dietary COS supplementation decreased FCR during days 6-14 (P < 0.05) and tended to improve average daily gain (ADG) over the same period (0.05 < P < 0.10). Moreover, COS tended to decrease faecal shedding of total E. coli (P = 0.085) and EHEC, attenuated systemic inflammation by decreasing serum TNF-α and IL-6 levels, and enhanced humoral immunity as indicated by increased IgA and IgM concentrations (P < 0.05). Importantly, COS alleviated EHEC-induced intestinal injury by restoring villus height and villus-to-crypt ratio, with enhanced mucosal digestive enzyme activities, and upregulated expression of tight junction proteins (ZO-1 and occludin) and nutrient transporters (SGLT-1 and PEPT1) (P < 0.05).
CONCLUSIONS: In conclusion, these findings indicate that dietary COS improves growth performance in EHEC-challenged weaned pigs, with enhanced intestinal barrier integrity and nutrient transport capacity.